Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation ISET 2019

5-Year Results from the IN.PACT SFA Randomized Trial

Presenter: Gary Ansel

January 30, 2019

Presentation TCT 2018

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

Presenter: William A. Gray

September 22, 2018

Presentation

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

May 08, 2018

Presentation VIVA 2017

Results from the IN.PACT SFA Randomized Trial

Presenter: Peter A. Schneider

September 15, 2017

Presentation ISET 2017

Failure of Stent Therapy

Presenter: Gary M. Ansel

February 04, 2017

Presentation

Role of Atherectomy

Presenter: Yoshimitsu Soga

January 14, 2017

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

Presentation Aortovascular 2015

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Presenter: Danielle R. Bajakian

September 18, 2015

Presentation Aortovascular 2015

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

Presenter: William A. Gray

September 18, 2015

Presentation CICT 2015

Drug Eluting Femoral Stents Where does it fit in my practice?

Presenter: Yazan Khatib

July 31, 2015

Presentation CCVVC 2015

My Algorithm for Treatment of Calcified SFA Lesions: Available Data, Role of DCB - DES, Atherectomy & Supera

Presenter: Fabrizio Fanelli

June 18, 2015

Presentation CCVVC 2015

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Presenter: Craig M. Walker

June 18, 2015

Presentation CCVVC 2015

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Presenter: Suhail Dohad

June 18, 2015

Presentation CCVVC 2015

Drug Coated Balloon in the Management of SFA Disease: Data & Current Trends

Presenter: Fabrizio Fanelli

June 18, 2015

Presentation ISET 2015

New Insights from the IN.PACT SFA Randomized Trial

Presenter: Gunnar Tepe

February 02, 2015

Presentation ISET 2015

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Presenter: Gunnar Tepe

February 02, 2015

Presentation ISET 2015

Results of Approved DCB in the United States

Presenter: Gary M. Ansel

February 01, 2015

Presentation ISET 2015

Benefits of DCB in SFA Disease

Presenter: Thomas Zeller

February 01, 2015

Presentation

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Presenter: Gunnar Tepe

April 14, 2014

Advertisement

Drug-Coated Therapy for ISR: Review of Options and Data

5-Year Results from the IN.PACT SFA Randomized Trial

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

Results from the IN.PACT SFA Randomized Trial

Failure of Stent Therapy

Role of Atherectomy

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet?

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

Drug Eluting Femoral Stents Where does it fit in my practice?

My Algorithm for Treatment of Calcified SFA Lesions: Available Data, Role of DCB - DES, Atherectomy & Supera

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Drug Eluting Stents in the treatment of SFA disease: Data and Current Trends

Drug Coated Balloon in the Management of SFA Disease: Data & Current Trends

New Insights from the IN.PACT SFA Randomized Trial

New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions

Results of Approved DCB in the United States

Benefits of DCB in SFA Disease

Randomized Trial of IN.PACT Admiral DCB vs PTA for Atherosclerotic Lesions in the SFA and/or PPA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content